Walleye Capital LLC Esperion Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $730 - $3,650	500 New	500 $0
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $75,210 - $112,194	13,800 New	13,800 $92,000
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $647,584 - $1.74 Million	-23,600 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $584,100 - $987,030	-16,500 Reduced 41.15%	23,600 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $1.34 Million - $1.84 Million	38,800 Added 2984.62%	40,100 $1.47 Million
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $501,250 - $654,125	-12,500 Reduced 90.58%	1,300 $60,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $553,518 - $739,266	13,800 New	13,800 $554,000

206

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $147M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.